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Available online 4 June 2016Rickettsia felis is an emerging zoonosis, causing ﬂea-borne spotted fever (FBSF). Serological diagnosis is typically
confounded by cross-reactivitywith typhus group rickettsiae and prior to the development of speciﬁc serological
methods, cases of FBSF in Australia were misdiagnosed.
Patient sera tested between August 2010 and December 2013 and known to be seropositive to R. typhi by
immunoﬂuorescence antibody testing (IFAT) were subsequently retested against R. felis using an R. felis-speciﬁc
IFAT. Sera of 49 patientswere of a sufﬁcient quality to be included in re-analysis. A classiﬁcation of FBSF andmurine
typhus (MT) was attributed to fourteen and seven patients respectively, based on a minimum four-fold higher
antibody titre to R. felis than to R. typhi and vice versa. Twenty-eight patients were classiﬁed as indeterminate
for either R. felis or R. typhi (antibody titres within two-fold of one another).
Historically, it is likely that Australian patients clinically ill with FBSF were misdiagnosed. It is important that
medical practitioners consider FBSF as part of their differential diagnoses, and obtain relevant historywith regard
to patient's exposure to domestic pets and their ﬂeas. Australian microbiology diagnostic laboratories should
include serological testing for R. felis as part of the diagnostic panel for febrile diseases. Veterinarians are
encouraged to increase their awareness of this emerging zoonosis and advocate ﬂea control in pets.








Rickettsia felis is an obligate intracellular bacterium that is being
increasingly recognised as an aetiological agent in human rickettsial
disease globally [1]. The agent is transmitted through the bite of an
infected vector, typically the cat ﬂea, Ctenocephalides felis [2]. Detection
of R. felis in cat ﬂeas has been reported globally, ranging from 15% in
New Zealand [3] to as high as 81% in New Caledonia [4]. In Australia,
infection rates in cat ﬂeas range between 20% in metropolitan centres
along the coast of eastern Australia to up to 36% in regional centres in
Western Australia [5,6].
Disease in humans is variously referred to as ﬂea-borne spotted
fever (FBSF), cat ﬂea typhus or cat ﬂea spotted fever. Symptoms of
infection range from non-speciﬁc ﬂu-like illness (fever, myalgia
and headache) to severe multi-systemic disease accompanied by a
maculopapular rash, due to widespread vasculitis [7–9]. In 2009, the
ﬁrst described Australian cases of FBSF occurred in a family from
Melbournewho had recently acquired R. felis positive C. felis ﬂea-ridden
kittens from a farm in Lara, Victoria [10].), sze.hii@unimelb.edu.au
s@bayer.com (R. Rees),
imelb.edu.au (R.J. Traub).
. This is an open access article underBlood and serum of suspected Australian cases of rickettsiosis were
sent to the Australian Rickettsial Reference Laboratory (ARRL) where
they underwent immunoﬂuorescence antibody testing (IFAT), the
gold standard for rickettsial serological diagnosis, to establish probable
exposure. Prior to the successful culture of R. felis in Australia in 2011
[11], serological protocols used at the ARRL did not screen speciﬁcally
for exposure to R. felis. As both R. typhi and R. felis cross-react using
IFAT, it is likely that a proportion of R. felis cases were misdiagnosed as
R typhi, a typhus group (TG) organism and agent of murine typhus,
which is also endemic to Australia [12].
The aim of this study was to retrospectively determine the exposure
and common clinical presentations associated with FBSF attributable to
R. felis in Australian patients referred to the ARRL in Geelong Australia
between August 2010 and December 2013. All R. typhi positive samples
reported in this period were re-examined in this study.2. Methods
2.1. Culture
R. feliswas cultured in a XTC-2 cell line at 28 °C in Leibovitz-15media
(GIBCO, Rockville,MD), supplementedwith 10% foetal calf serum, 2mM
L-glutamine and 5% tryptose phosphate broth [13]. R. typhiwas culturedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with 10% foetal calf serum and 2 mM L-glutamine. Once the cell lines
reached conﬂuency, they were infected with the appropriate rickettsia
and levels in the cell monolayers were monitored using a semi-
quantitative qPCRbased on the citrate synthase (gltA) gene [14]. Species
conﬁrmationwas achieved through PCR and DNA sequencing of the cit-
rate synthase (gltA) gene (Australian Genomic Research Facility Ltd.,
Australia). Monolayer cells infected with rickettsiae were harvested by
physical detachment using cell scrapers, and heat inactivated at 56 °C
for 30 min. The harvested material was then pelleted by centrifugation
at 3000 g for 10min at room temperature and the pellet resuspended in
PBS and evaluated using the IFAT. An optimal working dilution of
rickettsial antigen was established through serial doubling dilution of
the cell antigen preparations and gauging its ﬂuorescence in the IFAT.2.2. Ethics approval
Ethics approval for this study was granted through the University of
Melbourne Research Ethics Committee (ID: 1443252).2.3. Sample selection
Following the rickettsial serological testing of patient sera
referred to the ARRL, the samples were placed at −20 °C for long
term storage. A total of 136 serum samples that previously tested
positive for antibodies to R. typhi by IFAT between August 2010 and
December 2013 were screened, and of these, 69 serum samples
corresponding to 49 patients were of sufﬁcient quality (re-tested
reactive to R. felis or R. typhi antigen) to be included for the
retrospective assessment of R. felis exposure. FBSF infection was
conﬁrmed by demonstrating seroconversion in cases where paired
sera were available, or a four-fold difference in antibody titre to
R. felis compared to R. typhi when only single serum samples were
available. Additionally, data in relation to the patients' age, locality,
and clinical presentations were collected.Table 1
Overview of the FBSF-infected patient IFAT testing results.
Patient Age Locality Samp
Single sera
1 83 Sapphire Beach NSW, 2450 1
2 72 Fernmount NSW, 2454 1
3 71 Maleny QLD, 4552 1
4 58 Tamborine North QLD, 4272 1
5 36 Lalor VIC, 3075 1
Paired sera
6 30 Exmouth WA, 6707 1
2
7a 47 Fern Bay NSW, 2295 1
2
8a 56 Lauderdale TAS, 7021 1
2
9a 52 Charlestown NSW, 2290 1
2
10 23 Carey Bay NSW, 2283 1
2
11 69 Manyana NSW, 2539 1
2
12a 39 Cawongla NSW, 2474 1
2
13a 67 Eltham VIC, 3095 1
2
14 55 Mallanganee NSW, 2469 1
2
N/A = not applicable.
a Seroconverted paired sera.2.4. Immunoﬂuorescence antibody testing
A previously developed IFAT protocol [15] wasmodiﬁed and carried
out as follows; 40 well slides (Scientiﬁc Device Laboratory, Des Plaines,
IL) were washed in 100% acetic acid and antigen at its optimal concen-
tration was spotted onto each well. Once the antigen had air dried the
slides were ﬁxed in 100% acetone for 2 min. Serum samples were
serially diluted using 2% casein in PBS with a starting dilution of 1:128
and incubated at 34 °C for 40 min in a humid environment. Positive
and negative controls were diluted to 1:128 and included in each
assay run. Slideswere thenwashedwith 1/10 PBS, air-dried and spotted
with a 1:100 dilution of a ﬂuorescein isothiocyanate (FITC)-labelled
goat anti-human immunoglobulin IgG (H + L) (Kirkegaard & Perry
Laboratories, USA) and incubated at 34 °C for a further 40min. Following
the ﬁnal washing, the slides were air-dried, covered and stored in a dark
environment at 4 °C until read.
Each well was visualised by ﬂuorescence microscopy and the
end-point dilution titres determined. Readingwas repeated by a second
independent observer to control bias, with a third independent observer
recruited to resolve any discrepancies.3. Results
Of the 69 viable sera corresponding to 49 patients, 40 patients were
identiﬁed to be reactive to R. felis, and 14 patients had antibody titres to
R. felis four-fold or greater to that of R. typhi in either the acute or
convalescent sera (Table 1). These were classiﬁed as cases of FBSF.
Of these, nine patients had paired serum samples submitted and within
this group, ﬁve showed seroconversion, or a signiﬁcant rise in antibody
titre, indicating recent infection.
Forty-ﬁve patients remained reactive to R. typhi. Single serum
samples submitted by seven patients were classiﬁed as MT infections,
attributed to four-fold greater R. typhi antibody titres compared to
that of R. felis. The remaining serum samples representing 28 patients
were classiﬁed as indeterminate for either R. felis or R. typhi, possessing
antibody titres within two-fold of one another.Sample titrations
























Fig. 1. Location of retrospectively classiﬁed cases of ﬂea-borne spotted fever and murine typhus in Australia referred to the Australian Rickettsial Reference Laboratory 2010–2013.
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Tasmania and Western Australia (Fig. 1). Information on the clinical
presentation of FBSF was sparse and poorly recorded. Of the patients
with this information, febrile illness (n= 2), fatigue (n = 1), myalgia
(n= 1) and response to doxycycline (n= 1) were noted at presenta-
tion. There was no information recorded on the clinical presentation
of the conﬁrmed R. typhi patients.
4. Discussion
This is the ﬁrst study to retrospectively identify fourteen probable
cases of R. felis infection in patients in Australia between August 2010
and December 2013 using an R. felis speciﬁc IFAT. We demonstrate
that FBSF is a cause of rickettsial disease in Australia and was likely
misdiagnosed due to the unavailability of R. felis antigen for speciﬁc
testing at that time. Our results show that FBSF cases in Australia during
the period spanningAugust 2010 toDecember 2013were twice as com-
mon as those attributed to MT. This suggests the situation in Australia
resembles other parts of the world where R. felis has been shown to
be an important aetiological agent contributing to febrile illness [7,16].
This result is not surprising given the ubiquitous nature and high rates
of R. felis infection in C. felis populations in Australia [5,6].
Clinical data and history can be helpful in establishing a diagnosis of
rickettsial disease. In this case much of the data provided as part of the
sample submission process was missing or lacking in detail with regard
to the clinical syndrome and the patient's history of exposure to ﬂeas.The clinical syndrome of FBSF tends to include a series of non-speciﬁc
symptomsof varying occurrence: pyrexia,maculopapular rash,myalgia,
athralgia, headache, and fatigue [7,17–20]. These clinical signs cannot
distinguish from diseases caused by the other rickettsial organisms
endemic to Australia including Rickettsia australis (Queensland Tick
Typhus), Rickettsia honei (Flinders Island Spotted Fever), Rickettsia
honei subspeciesmarmionii (Australian Spotted Fever), R. typhi (murine
typhus), Orientia tsutsugamushi (Scrub Typhus) and Coxiella burnetii
(Q fever) [12]. While these patients may have been potentially
misclassiﬁed, the treatment of these rickettsial diseases is identical
[21]. It is critical that the distinction be made in order to better deﬁne
the epidemiology of these diseases which will allow for better medical
and laboratory diagnoses.
In contrast to the other tick- and “rodent ﬂea”-borne spotted
fevers endemic to Australia, FBSF is associated with exposure to the
commondomestic dog and cat ﬂea as opposed to arthropods commonly
associated with outdoor recreational activities in the Australian ‘bush’.
The source of these patients' exposure was not clear, mainly due to
the lack of relevant clinical history.
Rickettsia felis is transmitted via the bite of an infected ﬂea [2]. The
recognised vector, Ctenocephalides felis [22], is a widely distributed,
ubiquitous parasite of Australian companion animals [23] but will
readily feed on humans. In Australia, dogs have been implicated as
natural mammalian reservoirs for R. felis, based on their ability to
harbour naturally occurring, asymptomatic rickettsaemias [11,24,25];
Cats have not been shown to harbour natural R. felis rickettsaemias in
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Bangladesh [16].
In this study, we could deﬁnitively attribute FBSF infection in nine of
fourteen patient's sera found preferentially reactive to R. felis. Standard
diagnostic laboratory protocol for rickettsial IFAT measures an IgG
reaction, which isn't able to provide an indication on the acute nature
of an infection. An inherent limitation of the IFAT test is substantial
cross reactivity between antibodies to R. felis and R. typhi, owing to
shared genotypic and phenotypic features [26]. The requirement for
four-fold differences in titre between R. felis and R. typhi antibodies
was necessary to conﬁdently identify the aetiological agent. This
accounted for a large number of patients classiﬁed as indeterminate
for either R. felis and R. typhi exposure. Furthermore, it is impossible to
attribute the patient's symptoms and signs to an active FBSF infection
in the absence of a second convalescent serum sample demonstrating
changing titres.
Given the reported contribution of R. felis to non-speciﬁc febrile
illnesses in Australia [10], it is important that medical practitioners
consider FBSF as part of their differential diagnoses, and obtain relevant
history with regard to patient's exposure to domestic pets and their
ﬂeas. Multiple serum samples, collected between two to eight weeks
post infection, are needed for the conﬁrmation of FBSF. Australian
microbiology diagnostic laboratories should include serological testing
for R. felis as part of their diagnostic panels for febrile illness. Veterinar-
ians have an important role in advocating ﬂea control in domestic pets
and educating clients on the risks of ﬂea exposure amongst themselves
and their families.
Competing interests
The authors declare that they have no conﬂicts of interests.
Authors' contributions
YTT participated in the acquisition of data, analysis and interpreta-
tion of data, and drafting the manuscript. SFH and SG assisted with
analysis and interpretation of data and revising the article critically
for important intellectual content. RR assisted with study design and
revising the article critically for important intellectual content. JS and
RT assisted with study design, analysis and interpretation of data and
revising the article critically for important intellectual content. All
authors have read and approved the ﬁnal version of the manuscript.
Acknowledgements
This research was funded by the Australian Research Council
(LP130100565) in partnership with Bayer Animal Health and the
Australian Rickettsial Reference Laboratory. The authors would like to
thank Dr. Gemma Vincent and Ms. Chelsea Nguyen (Scientist Ofﬁcers
at the ARRL) for rickettsia cell culture, serological assay training and
IFAT validation.
References
[1] M.Y. Abdad, J. Stenos, S. Graves, Rickettsia felis, an emerging ﬂea-transmitted
human pathogen, Emerg. Health Threats J. 4 (2011), http://dx.doi.org/10.3402/
ehtj.v4i0.7168.
[2] E. Giudice, S. Di Pietro, A. Alaimo, V. Blanda, R. Lelli, F. Francaviglia, S. Caracappa, A.
Torina, A molecular survey of Rickettsia felis in ﬂeas from cats and dogs in Sicily
(southern Italy), PLoS ONE 9 (2014), e106820, http://dx.doi.org/10.1371/journal.
pone.0106820.
[3] P. Kelly, J.-M. Rolain, D. Raoult, Prevalence of human pathogens in cat and dog ﬂeas
in New Zealand, N.Z. Med. J. 118 (2005) U1754.
[4] O. Mediannikov, O. Cabre, F. Qu, C. Socolovschi, B. Davoust, J.-L. Marié, P. Parola, D.
Raoult, Rickettsia felis and Bartonella clarridgeiae in ﬂeas from New Caledonia,Vector-Borne Zoonotic Dis. 11 (2011) 181–183, http://dx.doi.org/10.1089/vbz.
2009.0199.
[5] D. Schloderer, H. Owen, P. Clark, J. Stenos, S.G. Fenwick, Rickettsia felis in ﬂeas,
Western Australia, Emerg. Infect. Dis. 12 (2006) 841.
[6] V. Barrs, J. Beatty, B. Wilson, N. Evans, R. Gowan, R. Baral, A. Lingard, G. Perkovic,
J. Hawley, M. Lappin, Prevalence of Bartonella species, Rickettsia felis,
haemoplasmas and the Ehrlichia group in the blood of cats and ﬂeas in eastern
Australia, Aust. Vet. J. 88 (2010) 160–165, http://dx.doi.org/10.1111/j.1751-
0813.2010.00569.x.
[7] A.N. Maina, D.L. Knobel, J. Jiang, J. Halliday, D.R. Feikin, S. Cleaveland, Z. Ng'ang'a, M.
Junghae, R.F. Breiman, A.L. Richards, M.K. Njenga, Rickettsia felis infection in febrile
patients, western Kenya, 2007–2010, Emerg. Infect. Dis. 18 (2012) 328–331,
http://dx.doi.org/10.3201/eid1802.111372.
[8] C. Socolovschi, O. Mediannikov, C. Sokhna, A. Tall, G. Diatta, H. Bassene, J.-F. Trape, D.
Raoult, Rickettsia felis-associated uneruptive fever, Senegal, Emerg. Infect. Dis. 16
(2010) 1140–1142, http://dx.doi.org/10.3201/eid1607.100070.
[9] F. Ferdouse, M.A. Hossain, S.K. Paul, S. Ahmed, M.C. Mahmud, R. Ahmed, A.K.M.F.
Haque, M.N.-A. Khan, S. Ghosh, N. Urushibara, N. Kobayashi, Rickettsia felis infection
among humans, Bangladesh, 2012–2013, Emerg. Infect. Dis. 21 (2015) 1483–1485,
http://dx.doi.org/10.3201/eid2108.150328.
[10] M. Williams, L. Izzard, S.R. Graves, J. Stenos, J.J. Kelly, First probable Australian cases
of human infection with Rickettsia felis (cat-ﬂea typhus), Med. J. Aust. 194 (2011)
(https://www.mja.com.au/journal/2011/194/1/ﬁrst-probable-australian-cases-
human-infection-rickettsia-felis-cat-ﬂea-typhus accessed March 12, 2014).
[11] S.-F. Hii, M.Y. Abdad, S.R. Kopp, J. Stenos, R.L. Rees, R.J. Traub, Seroprevalence and
risk factors for Rickettsia felis exposure in dogs from Southeast Queensland and
the northern territory, Australia, Parasit. Vectors 6 (2013) 159.
[12] S. Graves, J. Stenos, Rickettsioses in Australia, Ann. N. Y. Acad. Sci. 1166 (2009)
151–155, http://dx.doi.org/10.1111/j.1749-6632.2009.04530.x.
[13] W. Saisongkorh, K.E. Karkouri, J.-Y. Patrice, A. Bernard, J.-M. Rolain, D. Raoult,
Tryptose phosphate broth improves Rickettsia felis replication in mammalian cells,
FEMS Immunol. Med. Microbiol. 64 (2012) 111–114, http://dx.doi.org/10.1111/j.
1574-695X.2011.00882.x.
[14] M. Ishikura, S. Ando, Y. Shinagawa, K. Matsuura, S. Hasegawa, T. Nakayama, H. Fujita,
M. Watanabe, Phylogenetic analysis of spotted fever group rickettsiae based on
gltA, 17-kDa, and rOmpA genes ampliﬁed by nested PCR from ticks in Japan,
Microbiol. Immunol. 47 (2003) 823–832, http://dx.doi.org/10.1111/j.1348-0421.
2003.tb03448.x.
[15] S. Graves, B. Dwyer, D. McColl, J. McDade, Flinders Island spotted fever: a newly
recognised endemic focus of tick typhus in Bass Strait. Part 2. Serological investiga-
tions, Med. J. Aust. 154 (1991) 99–104.
[16] R. Ahmed, S.K. Paul, M.A. Hossain, S. Ahmed, M.C. Mahmud, S.A. Nasreen, F.
Ferdouse, R.H. Sharmi, F. Ahamed, S. Ghosh, N. Urushibara, M.S. Aung, N.
Kobayashi, Molecular detection of Rickettsia felis in humans, cats, and cat ﬂeas in
Bangladesh, 2013–2014, Vector-Borne Zoonotic Dis. (2016), http://dx.doi.org/10.
1089/vbz.2015.1886.
[17] A.L. Richards, J. Jiang, S. Omulo, R. Dare, K. Abdirahman, A. Ali, S.K. Sharif, D.R.
Feikin, R.F. Breiman, M.K. Njenga, Human infection with Rickettsia felis,
Kenya, Emerg. Infect. Dis. 16 (2010) 1081–1086, http://dx.doi.org/10.3201/
eid1607.091885.
[18] J. Richter, P.-E. Fournier, J. Petridou, D. Häussinger, D. Raoult, Rickettsia felis infection
acquired in Europe and documented by polymerase chain reaction, Emerg. Infect.
Dis. 8 (2002) 207.
[19] G. Mourembou, J.B. Lekana-Douki, O. Mediannikov, S.M. Nzondo, L.C. Kouna, J.C.B.B.
Essone, F. Fenollar, D. Raoult, Possible role of Rickettsia felis in acute febrile illness
among children in Gabon, Emerg. Infect. Dis. 21 (2015) 1808–1815, http://dx.doi.
org/10.3201/eid2110.141825.
[20] T.M. Parker, C.K. Murray, A.L. Richards, A. Samir, T. Ismail, M.A. Fadeel, J. Jiang, M.O.
Wasfy, G. Pimentel, Concurrent infections in acute febrile illness patients in Egypt,
Am.J.Trop. Med. Hyg. 77 (2007) 390–392.
[21] L. Hun, A. Troyo, An update on the detection and treatment of Rickettsia felis, Res.
Rep. Trop. Med. 47 (2012), http://dx.doi.org/10.2147/RRTM.S24753.
[22] J.R. Adams, E.T. Schmidtmann, A.F. Azad, Infection of colonized cat ﬂeas,
Ctenocephalides felis (Bouche), with a rickettsia-like microorganism, Am.J.Trop.
Med. Hyg. 400 (1990).
[23] J. Šlapeta, J. King, D. McDonell, R. Malik, D. Homer, P. Hannan, D. Emery, The cat ﬂea
(Ctenocephalides f. felis) is the dominant ﬂea on domestic dogs and cats in Australian
veterinary practices, Vet. Parasitol. 180 (2011) 383–388, http://dx.doi.org/10.1016/j.
vetpar.2011.03.035.
[24] S.-F. Hii, S.R. Kopp, M.F. Thompson, C.A. O'Leary, R.L. Rees, R.J. Traub, Molecular
evidence of Rickettsia felis infection in dogs from Northern Territory, Australia,
Parasit. Vectors 4 (2011) 1756–3305.
[25] S.F. Hii, S.R. Kopp, M.Y. Abdad, M.F. Thompson, C.A. O'Leary, R.L. Rees, R.J. Traub,
Molecular evidence supports the role of dogs as potential reservoirs for Rickettsia
felis, Vector-Borne Zoonotic Dis. 11 (2011) 1007–1012, http://dx.doi.org/10.1089/
vbz.2010.0270.
[26] J.J. Gillespie, M.S. Beier, M.S. Rahman, N.C. Ammerman, J.M. Shallom, A.
Purkayastha, B.S. Sobral, A.F. Azad, Plasmids and rickettsial evolution: insight
from Rickettsia felis, PLoS ONE 2 (2007), e266, http://dx.doi.org/10.1371/
journal.pone.0000266.
